Muhammad Sajid, MD
Child & Adolescent Psychiatry · Gainesville, FLNPI 1801825500
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,650 of the $4,650 with a category attached, or 78.5%. It is spread thinly across 26 manufacturers, the largest accounting for just 21.5% — the pattern of someone who eats at a lot of different presentations.
Across 183 payments — averaging $25.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- Teva Pharmaceuticals USA, Inc.$737
- Supernus Pharmaceuticals, Inc.$478
- Vanda Pharmaceuticals Inc.$476
- Johnson & Johnson$251
- Corium, LLC$220
- plus $1K from 20 others
What the payments were for
- Speaking & faculty fees$1,00022%
- Food & beverage$3,65078%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,650 in reported general payments places this provider in the 85th percentile of 206 child & adolescent psychiatry providers in Florida.
See all child & adolescent psychiatry providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Quetiapine Fumarate | 12 | $119 |
| Duloxetine Hcl | 11 | $115 |
Paid to pharmacies, not to this prescriber.
Other child & adolescent psychiatry in Gainesville
- Elias SarkisGainesville$169K
- Ayesha LallGainesville$4K
- Amparo Benitez-BroomeGainesville$2K
- Craig KuninsGulfport$265K
- Jeffrey AlvaroSt Petersburg$87K
- Rosa Negron MunozLakeland$39K
- Sean HoranMiami$17K
- Rachel AgustinesLargo$16K
- Carlos BorgeSarasota$15K
- Justin SpoonerPonte Vedra Beach$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.